
EVERSANA adds AI to medical, legal and regulatory reviews
A new AI-powered solution from EVERSANA aims to take the pain out of medical, legal and regulatory (MLR) reviews.
Newsletters and Deep Dive digital magazine
A new AI-powered solution from EVERSANA aims to take the pain out of medical, legal and regulatory (MLR) reviews.
The opening sessions of Reuters Pharma Europe 2025 focused on global access challenges and the transformative potential of AI.
This pre-recorded webinar was fully funded by Chiesi GRD and hosted by pharmaphorum. Professor Maurizio Scarpa received an honorarium for his participation and contribution to this webinar.
Brainomix has been granted FDA approval for a new feature for its AI-powered stroke imaging software that could unlock wider use in the US.
The UK government and Wellcome Trust will invest £600m in a Health Data Research Service to unlock the power of NHS patient data for medical research.
Editor's Picks
Newsletters and Deep Dive
digital magazine